date,title,source
Oct-17-18,Bristol-Myers Squibb to Showcase Immunoscience Research and Biomarker-Guided Treatment Approaches at the 2018 American College of Rheumatology and Association of Rheumatology Health Professionals Annual Meeting,Business Wire
Oct-19-18,Bristol-Myers Squibb Provides Update on the Ongoing Regulatory Review of Opdivo Plus Low-Dose Yervoy in First-Line Lung Cancer Patients with Tumor Mutational Burden 10 mut/Mb,Business Wire
Oct-19-18,BMY vs. LLY: Which Stock Should Value Investors Buy Now?,Zacks
Oct-19-18,"Today's Research Reports on Trending Tickers: Merck & Co., and Bristol-Myers Squibb",ACCESSWIRE
Oct-22-18,[$$] Bristol-Myers Faces a Costly Delay,The Wall Street Journal
Oct-22-18,Why Nektar Therapeutics Crashed 17.2% Today,Motley Fool
Oct-22-18,Mirati Shares Fall After Cancer Trial Progress Report,TheStreet.com
Oct-22-18,MarketPulse: Healthcare Slips as Bristol-Myers Squibb Sinks,Investing.com
Oct-22-18,Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy,TheStreet.com
Oct-22-18,"Dow Trades Lower After Momentum From China Rally Fades, Nasdaq Rises",TheStreet.com
Oct-22-18,Will Bristol-Myers move higher? Is Activision Blizzard ov...,CNBC Videos
Oct-22-18,[$$] Bristol-Myers Faces a Costly Delay,The Wall Street Journal
Oct-22-18,Why Mirati Therapeutics Inc. Is Plunging Today,Motley Fool
Oct-22-18,Mirati Therapeutics stock drops 19.5% after cancer trial results,MarketWatch
Oct-22-18,Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug,MarketWatch
Oct-22-18,Is a Beat in Store for Bristol-Myers (BMY) in Q3 Earnings?,Zacks
Oct-22-18,Are Bristol-Myers Squibb Companys (NYSE:BMY) Interest Costs Too High?,Simply Wall St.
Oct-22-18,Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Results in Significantly Longer Treatment-Free Survival in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma,Business Wire
Oct-22-18,Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Durable Four-Year Survival Benefits in Patients with Advanced Melanoma,Business Wire
Oct-22-18,Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Durable Clinical Benefit in Previously Untreated Patients with MSI-H or dMMR Metastatic Colorectal Cancer,Business Wire
Oct-23-18,"Bristol-Myers Declines, FDA Delays Review of Opdivo for NSCLC",Zacks
Oct-23-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers",Zacks
Oct-24-18,Bristol-Myers Squibb Q3 Earnings Outlook,Benzinga
Oct-24-18,"Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG",Zacks
Oct-25-18,Bristol-Myers Squibb Co (BMY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-25-18,"Pharma Giants Merck, Bristol Diverge On Earnings Beat As Sales Lag",Investor's Business Daily
Oct-25-18,Merck and Bristol-Myers Squibb Are Seeing Rising Sales of Their Cancer Drugs,Barrons.com
Oct-25-18,"Bristol-Myers (BMY) Beats on Q3 Earnings, Raises EPS View",Zacks
Oct-25-18,"Merck, Bristol-Myers profits rise on cancer drug sales",Reuters
Oct-25-18,"Bristol-Myers Beats Q3 Earnings, Boosts Full-Year Outlook on Solid Opdivo Sales",TheStreet.com
Oct-25-18,Why Bristol-Myers Squibb (BMY) is a Top Dividend Stock for Your Portfolio,Zacks
Oct-25-18,A Spotlight On Bristol-Myers Squibb Companys (NYSE:BMY) Fundamentals,Simply Wall St.
Oct-25-18,Bristol-Myers Squibb (BMY) Q3 Earnings Beat Estimates,Zacks
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-29-18,Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know,Zacks
Oct-29-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised)",Zacks
Oct-30-18,Is Halloween the Best Time to Invest? 5 Solid Buys,Zacks
Oct-31-18,The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead,Zacks
Oct-31-18,"Zacks.com highlights: Bristol-Myers Squibb, United Rentals, Capital One Financial and Harris",Zacks
Oct-31-18,"The Zacks Analyst Blog Highlights: ArcBest, Express, Arch Coal, Bristol-Myers Squibb and Methanex",Zacks
Oct-31-18,Edited Transcript of BMY earnings conference call or presentation 25-Oct-18 2:30pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Edited Transcript of BMY earnings conference call or presentation 25-Oct-18 2:30pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Bristol-Myers Squibb plans layoffs of ZymoGenetics' remaining Seattle-area employees,American City Business Journals
Nov-01-18,"Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales",Zacks
Nov-01-18,"Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View",Zacks
Nov-02-18,"AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues",Zacks
Nov-05-18,"Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates",Zacks
Nov-05-18,Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q3,Zacks
Nov-05-18,"The Zacks Analyst Blog Highlights: Newfield Exploration, Amazon.com, Bristol-Myers Squibb, Eaton and CF Industries Holdings",Zacks
Nov-05-18,Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer,PR Newswire
Nov-07-18,"Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View",Zacks
Nov-07-18,"Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer",Zacks
Nov-07-18,Why Nektar Therapeutics Fell 36.5% in October,Motley Fool
Nov-07-18,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",Benzinga
Nov-07-18,Bristol-Myers Squibb to Take Part in Credit Suisse 2018 Health Care Conference,Business Wire
Nov-08-18,Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know,Zacks
Nov-08-18,"Stada, Angelini among final bidders for $1 billion Bristol-Myers' UPSA unit - sources",Reuters
Nov-08-18,"Stada, Angelini among final bidders for $1 bln Bristol-Myers' UPSA unit - sources",Reuters
Nov-08-18,"Stada, Angelini among final bidders for $1 bln Bristol-Myers' Upsa unit - sources",Reuters
Nov-08-18,Edited Transcript of BMY earnings conference call or presentation 25-Oct-18 2:30pm GMT,Thomson Reuters StreetEvents
Nov-08-18,"Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise",Zacks
Nov-08-18,Immune Design (IMDZ) Posts Narrower-Than-Expected Loss in Q3,Zacks
Nov-08-18,"Alnylam's (ALNY) Q3 Loss Narrower Than Expected, Sales Miss",Zacks
Nov-08-18,Democrats Hold Edge in House Battle: 5 Great Picks (Revised),Zacks
Nov-08-18,Wall Street Likely to Sustain Post-Midterm Rally: 5 Picks,Zacks
Nov-09-18,Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update,Zacks
Nov-09-18,"Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag",Zacks
Nov-09-18,Highly Rated 'Surgeon' For Biologic-Drug Makers Soars 85% In 2018,Investor's Business Daily
Nov-09-18,"The Zacks Analyst Blog Highlights: DXP Enterprises, Bristol-Myers Squibb, EnPro Industries, Illumina and NetApp",Zacks
Nov-09-18,"Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug",Zacks
Nov-09-18,Today's Research Reports on Trending Tickers: AstraZeneca and Bristol-Myers Squibb,ACCESSWIRE
Nov-12-18,Nektar Bounds Higher On 'Promising Contender' In Cancer Immunotherapy,Investor's Business Daily
Nov-12-18,Today's Research Reports on Trending Tickers: Heron Therapeutics and Bristol-Myers Squibb,ACCESSWIRE
Nov-13-18,"Bayer (BAYRY) Beats on Q3 Earnings, Revenue Estimates",Zacks
Nov-13-18,Today's Research Reports on Trending Tickers: Nektar Therapeutics and Bristol-Myers Squibb,ACCESSWIRE
Nov-14-18,Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know,Zacks
Nov-14-18,Can These 2 Battered Biotech Stocks Recover?,Motley Fool
Nov-14-18,Shire's Filing Accepted by FDA for Gattex's Label Expansion,Zacks
Nov-16-18,Bristol-Myers' Opdivo Receives Positive CHMP Opinion for RCC,Zacks
Nov-16-18,Is Paypal Holdings Inc (PYPL) A Good Investment Right Now?,Insider Monkey
Nov-16-18,"Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings",Zacks
Nov-16-18,"The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal",Benzinga
Nov-19-18,"AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down",Zacks
Nov-20-18,Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know,Zacks
Nov-20-18,"Investor Expectations to Drive Momentum within Bristol-Myers Squibb, Leaf Group, SendGrid, Exantas Capital, Under Armour, and Medley Management  Discovering Underlying Factors of Influence",GlobeNewswire
Nov-20-18,Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails,Zacks
Nov-20-18,Bristol-Myers Squibb to Take Part in Evercore ISI HealthCONx Conference,Business Wire
Nov-21-18,"Mylan Recalls Valsartan Lots, Gets FDA Warning for Facility",Zacks
Nov-21-18,Shire-Takeda Deal Gets Phase I Conditional European Approval,Zacks
Nov-21-18,Is Bristol-Myers (BMY) a Great Stock for Value Investors?,Zacks
Nov-21-18,"Clovis' (CLVS) Rubraca Gets Another US Patent, Shares Up",Zacks
Nov-23-18,Bayer Hurts from Generic Competition & Pipeline Setbacks,Zacks
Nov-26-18,AMAG's Label Expansion of Lead Products Raises Share Price,Zacks
Nov-26-18,"After-hours buzz: AAPL, GM & more",CNBC
Nov-26-18,Bristol-Myers Squibb says cancer drug combination fails late-stage trial,Reuters
Nov-26-18,Bristol-Myers Squibb shares decline on failed lung-cancer drug study,MarketWatch
Nov-26-18,Bristol-Myers Squibb Announces CheckMate -451 Study Did Not Meet Primary Endpoint of Overall Survival with Opdivo Plus Yervoy Vs. Placebo as A Maintenance Therapy in Patients with Extensive-Stage Small Cell Lung Cancer After Completion of First-Line Chemotherapy,Business Wire
Nov-26-18,Glaxo Inks Marketing Deal for Anaemia Candidate in Japan,Zacks
Nov-26-18,"Bristol-Myers Squibb Awards Golden Tickets for LabCentral to ReviveMed, Strand Therapeutics",Business Wire
Nov-27-18,What Happened in the Stock Market Today,Motley Fool
Nov-27-18,Spirit Airlines jumps while United Technologies tumbles,Associated Press
Nov-27-18,US STOCKS-Wall St reverses losses after White House adviser's trade remarks,Reuters
Nov-27-18,"Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate",Zacks
Nov-27-18,Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial,Zacks
Nov-27-18,This Pharma Giant Is Still Consolidating Despite Lung Cancer Flop,Investor's Business Daily
Nov-27-18,Bristol-Myers Drops After Lung-Cancer Drug Study Fails,TheStreet.com
Nov-27-18,Glaxo (GSK) and J&J's HIV Drug Juluca Gets Approval in Japan,Zacks
Nov-27-18,"[$$] Stocks to Watch: Apple, GM, United Technologies",The Wall Street Journal
Nov-27-18,Dont Sell Bristol-Myers Squibb Company (NYSE:BMY) Before You Read This,Simply Wall St.
Nov-27-18,Bayer's TRK Inhibitor Gets FDA Nod for Advanced Solid Tumors,Zacks
Nov-27-18,"Stocks making the biggest move premarket: UTX, AAPL, HIBB, NVS, TSLA & more",CNBC
Nov-27-18,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",Benzinga
Nov-28-18,Bristol-Myers Squibb (BMY) Gains But Lags Market: What You Should Know,Zacks
Nov-28-18,Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity,Zacks
Nov-28-18,"Company News For Nov 28, 2018",Zacks
Nov-28-18,Todays Research Reports on Stocks to Watch: IntelliPharmaCeutics International and Bristol-Myers Squibb,ACCESSWIRE
Nov-29-18,Bristol-Myers Squibb to Highlight New Data from Broad Oncology Portfolio at the 60th American Society of Hematology Annual Meeting,Business Wire
Nov-29-18,Catalyst's Firdapse Receives FDA Approval for Rare Disease,Zacks
Nov-29-18,Bristol-Myers Squibb to Take Part in Citi 2018 Global Healthcare Conference,Business Wire
Nov-30-18,Novartis' Gilenya Approved in EU for Expanded Population,Zacks
Nov-30-18,Lilly (LLY) Hits Fresh High: Is There Still Room to Run?,Zacks
Nov-30-18,Bayer (BAYRY) to Restructure Business & Reduce Headcount,Zacks
Dec-03-18,Bristol-Myers Squibb to Transfer $3.8 billion in U.S. Pension Liabilities,Business Wire
Dec-03-18,Shire's Takhzyro Gets European Nod for Hereditary Angioedema,Zacks
Dec-03-18,5 Best Stocks to Own This December,Zacks
